SCHEMBL789515

SCHEMBL789515

C/C=C\C=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135481 1.00
SCHEMBL135480 1.00
SCHEMBL28102564 1.00 TRPA1 (0.33)
Water SCHEMBL27588993 0.96
Carbon Dioxide SCHEMBL27808258 0.87 TRPA1 (0.33)
SCHEMBL7801159 0.86
SCHEMBL7801161 0.86
SCHEMBL1270866 0.79 TSHR (0.30)
SCHEMBL1270865 0.79 TSHR (0.30)
SCHEMBL9936581 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230124929-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-04-20 US disclosed
US-11384381-B2 Reaction accelerating agent KIKKOMAN CORPORATION (JP) 2022-07-12 US disclosed
US-11358939-B2 1,4-benzodiazepin-2-one derivatives and use thereof INNOVATION PHARMACOLOGY RESEARCH OOO (IPHAR) (RU) 2022-06-14 US disclosed
EP-3928779-A1 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. Chugai Seiyaku Kabushiki Kaisha (JP) 2021-12-29 EP disclosed
US-11118014-B2 Polymer compound, intermediate composition, negative electrode, electricity storage device, and method for producing polymer compound KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2021-09-14 US disclosed
US-20210187005-A1 PHARMACEUTICAL COMPOSITION KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) 2021-06-24 US disclosed
EP-3834827-A1 N-[5-(3,5-DIFLUOROBENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YLAMINO) BENZAMIDE FOR TREATING PATIENTS WITH ROS1,NTRK1, NTRK2 AND NTRK3 MUTANT CANCER CELLS Ignyta, Inc. (US) 2021-06-16 EP disclosed
EP-3196201-B1 POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE-INHIBITING ACTIVITY SHIONOGI & CO (JP) 2021-04-28 EP disclosed
EP-3107541-B1 COMPOUNDS FOR TREATING PATIENTS WITH ROS1 MUTANT CANCER CELLS IGNYTA INC (US) 2020-12-23 EP disclosed
US-20200377487-A1 SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2020-12-03 US disclosed
US-9931624-B2 Anion exchange resin, electrolyte membrane for fuel cell, binder for forming electrode catalyst layer, battery electrode catalyst layer and fuel cell TAKAHATA PRECISION JAPAN CO., LTD. (JP) 2018-04-03 US disclosed
US-9783545-B2 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome USHER III INITIATIVE, INC. (US) 2017-10-10 US disclosed
US-9707212-B2 S-nitrosoglutathione reductase inhibitors NIVALIS THERAPEUTICS, INC. (US) 2017-07-18 US disclosed
US-20170087545-A1 ANION EXCHANGE RESIN, ELECTROLYTE MEMBRANE FOR FUEL CELL, BINDER FOR FORMING ELECTRODE CATALYST LAYER, BATTERY ELECTRODE CATALYST LAYER AND FUEL CELL TAKAHATA PRECISION JAPAN CO., LTD. (JP) 2017-03-30 US disclosed
EP-2616473-B1 MIXTURES CONTAINING PHOSPHOROUS, PROCEDURES FOR THEIR PRODUCTION AND USE CLARIANT INT LTD (CH) 2016-11-09 EP disclosed
CN-103221416-B Containing phosphate mixture, Its Preparation Method And Use CLARIANT FINANCE (BVI) LTD. (VG) 2016-04-20 CN disclosed
EP-2616473-A2 PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF Clariant Finance (BV) Limited (VG) 2013-07-24 EP disclosed
US-20130172457-A1 Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2013-07-04 US disclosed
EP-2543706-A2 Stabilizer of color former and use thereof ARKRAY, Inc. (JP) 2013-01-09 EP disclosed
WO-2012034680-A2 PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2012-03-22 WO disclosed